Jernigan continues prominent role on national advisory board for Susan G. Komen

Susan G. Komen Greater Kansas City is proud to continue local representation on the Susan G. Komen Scientific Advisory Board (SAB): Cheryl Jernigan, CPA, FACHE. Jernigan also serves on the Komen Kansas City Board of Directors. Her focus continues to be on patient and research advocacy; clinical trials, clinical data research; big data (BD4BC); and cancer prevention. Jernigan is also a 21-year breast cancer survivor and one of the leading team captains (based on dollars raised) for the local Race for the Cure.

Cheryl Jernigan - Mission Advisors Roster FY18_Page_1She was previously CEO of the Kansas City Area Hospital Association, and has over 20 years of experience in health policy, advocacy and community/national leadership on behalf of hospitals. She is Chair of the Breast Cancer Prevention Center’s Advocate Advisory Board for The University of Kansas Medical Center and The University of Kansas Hospital, and she is the Lead Advocate of Patient & Investigator Voices Organizing Together (PIVOT), a new University of Kansas Cancer Center initiative. Jernigan is a founding and current board member and Chair of the Strategic Mission Committee of the Greater Kansas City Komen Affiliate, and a member of the Steering Committee of Komen’s Advocates In Science program. An active research advocate, Jernigan is a member of many clinical trial initiatives, including the National Cancer Institute’s Central Institutional Review Board for Adult Late Phase Clinical Trials. Jernigan is also one of the experts involved with Komen’s big data initiative.

In addition to Jernigan, the Greater Kansas City community is fortunate to be the home of Komen Scholar Danny Welch, PHDProfessor and Chair, Adjunct faculty of Department of Molecular & Integrative Physiology. Welch, a researcher at the University of Kansas Medical Center, focuses on laboratory and translational research; metastasis; as well as mitochondrial genetics and mutations that lead to breast cancer. Welch is also a multi-year recipient of Komen Promise Grant dollars for his work on metastasis.

Click here to see a full list of the 2017-2018 Komen Mission Advisors..

Komen’s Mission Advisors

Komen’s Mission Advisors are the best and brightest researchers, clinicians, advocates & other experts who guide/help implement our mission programs.

Thanks to their efforts, we’re driving discovery, affecting change & accelerating progress in the fight against breast cancer.

The Scientific Advisory Board are providing strategic guidance for our research & scientific programs. They play a key role in prioritizing our global research investment. The SAB is led by the chief scientific advisors & acts as the executive committee of the Komen Scholars.

The Komen Scholars (KS) are an international group that has a wide range of expertise (clinical & laboratory research, surgery, pathology, prevention, disparities, radiation   oncology & other specialties).

They contribute in many ways to Komen’s mission programs & other activities/events with primary responsibility for leading & reviewing during Komen’s scientific peer review process. KS serve as ambassadors & experts in our communities and across the Affiliate Network.

Several of the KS are Advocates in Science who ensure that the unique perspectives of those affected by breast cancer are fully integrated in our decisions at every step of the research process.

Why Komen?

How do we boil this down to just one post? Here are some of the highlights in addition to our industry leading approach in fighting breast cancer on all fronts (Education, Awareness, Screenings, Treatment, Advocacy & Research):

2016-why-komen-graphic

About Susan G. Komen®
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Since its founding in 1982, Komen has funded more than $920 million in research and provided more than $2 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

About Susan G. Komen® Greater Kansas City
Susan G. Komen® Greater Kansas City is working to better the lives of those facing breast cancer in the local community. Through events like the Komen Kansas City Race for the Cure®, Rock the Ribbon and the Pink Promise Conference, Komen KC has invested more than $20 million in community breast health programs throughout 17 Kansas and Missouri counties and has helped contribute to the more than $920 million invested globally in research. Visit komenkansascity.org or call 816.842.0410. Connect with us on social media including the following sites: